The Neurodegenerative Disorder Therapeutics market was valued at USD 17.30 Billion in 2024 and is expected to reach USD 26.89 Billion by 2032, growing at a CAGR of 5.67% (2024-2032) https://www.databridgemarketresearch.com/reports/global-neurodegenerative-disorder-therapeutics-market